BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kudela E, Samec M, Kubatka P, Nachajova M, Laucekova Z, Liskova A, Dokus K, Biringer K, Simova D, Gabonova E, Dankova Z, Biskupska Bodova K, Zubor P, Trog D. Breast Cancer in Young Women: Status Quo and Advanced Disease Management by a Predictive, Preventive, and Personalized Approach. Cancers (Basel) 2019;11:E1791. [PMID: 31739537 DOI: 10.3390/cancers11111791] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Smolarz B, Nowak AZ, Romanowicz H. Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). Cancers (Basel) 2022;14:2569. [PMID: 35626173 DOI: 10.3390/cancers14102569] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Zadrożna-nowak A, Romanowicz H, Zadrożny M, Bryś M, Forma E, Smolarz B. Analysis of Long Non-Coding RNA (lncRNA) uc.38 and uc.63 Expression in Breast Carcinoma Patients. Genes 2022;13:608. [DOI: 10.3390/genes13040608] [Reference Citation Analysis]
3 Gómez-Flores-Ramos L, Barraza-Arellano AL, Mohar A, Trujillo-Martínez M, Grimaldo L, Ortiz-Lopez R, Treviño V. Germline Variants in Cancer Genes from Young Breast Cancer Mexican Patients. Cancers (Basel) 2022;14:1647. [PMID: 35406420 DOI: 10.3390/cancers14071647] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sahin G, Goker ENT, Gokmen E, Yeniay L, Acet F, Zekioglu O, Tavmergen E. Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre. J Obstet Gynaecol 2021;:1-6. [PMID: 34382483 DOI: 10.1080/01443615.2021.1931067] [Reference Citation Analysis]
5 Varty K, O'Brien C, Ignaszak A. Breast Cancer Aptamers: Current Sensing Targets, Available Aptamers, and Their Evaluation for Clinical Use in Diagnostics. Cancers (Basel) 2021;13:3984. [PMID: 34439139 DOI: 10.3390/cancers13163984] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Martini R, Chen Y, Jenkins BD, Elhussin IA, Cheng E, Hoda SA, Ginter PS, Hanover J, Zeidan RB, Oppong JK, Adjei EK, Jibril A, Chitale D, Bensenhaver JM, Awuah B, Bekele M, Abebe E, Kyei I, Aitpillah FS, Adinku MO, Ankomah K, Osei-Bonsu EB, Nathansan SD, Jackson L, Jiagge E, Petersen LF, Proctor E, Nikolinakos P, Gyan KK, Yates C, Kittles R, Newman LA, Davis MB. Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort. Sci Rep 2021;11:9247. [PMID: 33927264 DOI: 10.1038/s41598-021-88613-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Lin H, Shi L, Zhang J, Zhang J, Zhang C. Epidemiological characteristics and forecasting incidence for patients with breast cancer in Shantou, Southern China: 2006-2017. Cancer Med 2021;10:2904-13. [PMID: 33724693 DOI: 10.1002/cam4.3843] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Labrosse J, Lecourt A, Hours A, Sebbag C, Toussaint A, Laas E, Coussy F, Grandal B, Dumas E, Daoud E, Morel C, Feron JG, Faron M, Pierga JY, Reyal F, Hamy AS. Time to Pregnancy, Obstetrical and Neonatal Outcomes after Breast Cancer: A Study from the Maternity Network for Young Breast Cancer Patients. Cancers (Basel) 2021;13:1070. [PMID: 33802333 DOI: 10.3390/cancers13051070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Liskova A, Samec M, Koklesova L, Kudela E, Kubatka P, Golubnitschaja O. Mitochondriopathies as a Clue to Systemic Disorders-Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine. Int J Mol Sci 2021;22:2007. [PMID: 33670490 DOI: 10.3390/ijms22042007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
10 Hirschfeld M, Rücker G, Weiß D, Berner K, Ritter A, Jäger M, Erbes T. Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection. Mol Diagn Ther 2020;24:215-32. [PMID: 32112368 DOI: 10.1007/s40291-020-00453-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
11 Zhu X, Dent S, Paquet L, Zhang T, Tesolin D, Graham N, Aseyev O, Song X. How Canadian Oncologists Use Oncotype DX for Treatment of Breast Cancer Patients. Curr Oncol 2021;28:800-12. [PMID: 33557029 DOI: 10.3390/curroncol28010077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ortega MA, Fraile-Martínez O, García-Montero C, Pekarek L, Guijarro LG, Castellanos AJ, Sanchez-Trujillo L, García-Honduvilla N, Álvarez-Mon M, Buján J, Zapico Á, Lahera G, Álvarez-Mon MA. Physical Activity as an Imperative Support in Breast Cancer Management. Cancers (Basel) 2020;13:E55. [PMID: 33379177 DOI: 10.3390/cancers13010055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
13 Kudela E, Samec M, Koklesova L, Liskova A, Kubatka P, Kozubik E, Rokos T, Pribulova T, Gabonova E, Smolar M, Biringer K. miRNA Expression Profiles in Luminal A Breast Cancer-Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment. Int J Mol Sci 2020;21:E7691. [PMID: 33080858 DOI: 10.3390/ijms21207691] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
14 Sun Y, Li Y, Wu J, Tian H, Liu H, Fang Y, Li Y, Yu F. Nomograms for prediction of overall and cancer-specific survival in young breast cancer. Breast Cancer Res Treat 2020;184:597-613. [PMID: 32886273 DOI: 10.1007/s10549-020-05870-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Samec M, Liskova A, Koklesova L, Samuel SM, Zhai K, Buhrmann C, Varghese E, Abotaleb M, Qaradakhi T, Zulli A, Kello M, Mojzis J, Zubor P, Kwon TK, Shakibaei M, Büsselberg D, Sarria GR, Golubnitschaja O, Kubatka P. Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism. EPMA J 2020;11:377-98. [PMID: 32843908 DOI: 10.1007/s13167-020-00217-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 55] [Article Influence: 16.0] [Reference Citation Analysis]
16 Blasiak J, Pawlowska E, Chojnacki J, Szczepanska J, Fila M, Chojnacki C. Vitamin D in Triple-Negative and BRCA1-Deficient Breast Cancer-Implications for Pathogenesis and Therapy. Int J Mol Sci 2020;21:E3670. [PMID: 32456160 DOI: 10.3390/ijms21103670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
17 Zubor P, Dankova Z, Kolkova Z, Holubekova V, Brany D, Mersakova S, Samec M, Liskova A, Koklesova L, Kubatka P, Bujnak J, Kajo K, Mlyncek M, Giordano FA, Golubnitschaja O. Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare. Cancers (Basel) 2020;12:E1292. [PMID: 32443784 DOI: 10.3390/cancers12051292] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
18 Zhen X, Choi HS, Kim JH, Kim SL, Liu R, Yun BS, Lee DS. Machilin D, a Lignin Derived from Saururus chinensis, Suppresses Breast Cancer Stem Cells and Inhibits NF-κB Signaling. Biomolecules 2020;10:E245. [PMID: 32033472 DOI: 10.3390/biom10020245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]